Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scienjoy Holding (SJ) Notes Payables (2018 - 2023)

Historic Notes Payables for Scienjoy Holding (SJ) over the last 5 years, with Q4 2023 value amounting to $5.2 million.

  • Scienjoy Holding's Notes Payables rose 64450.18% to $5.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $5.2 million, marking a year-over-year increase of 64450.18%. This contributed to the annual value of $5.2 million for FY2023, which is 64450.18% up from last year.
  • As of Q4 2023, Scienjoy Holding's Notes Payables stood at $5.2 million, which was up 64450.18% from $690000.0 recorded in Q2 2023.
  • Over the past 5 years, Scienjoy Holding's Notes Payables peaked at $12.3 billion during Q1 2021, and registered a low of -$4.1 million during Q4 2021.
  • In the last 4 years, Scienjoy Holding's Notes Payables had a median value of $2.5 billion in 2022 and averaged $4.7 billion.
  • In the last 5 years, Scienjoy Holding's Notes Payables soared by 141656666.67% in 2019 and then crashed by 5640.04% in 2022.
  • Over the past 4 years, Scienjoy Holding's Notes Payables (Quarter) stood at $5.5 billion in 2019, then tumbled by 100.07% to -$4.1 million in 2021, then surged by 117.29% to $703020.5 in 2022, then skyrocketed by 644.5% to $5.2 million in 2023.
  • Its Notes Payables was $5.2 million in Q4 2023, compared to $690000.0 in Q2 2023 and $728000.0 in Q1 2023.